期刊文献+

血清胱抑素C与2型糖尿病下肢血管病变的相关性研究 被引量:2

Related research of serum cystatin C and peripheral vascular disease in type 2 diabetes
原文传递
导出
摘要 目的:探讨血清胱抑素C(Cys C)与2型糖尿病下肢血管病变的关系。方法:采用下肢动脉彩色多普勒超声筛查我院内分泌科糖尿病住院患者100例,糖尿病有下肢血管病变者(PVD)50例,糖尿病无下肢血管病变者(NPVD)50例;正常人(NC)40例。测定血清胱抑素C浓度、血脂等指标,并测定其临床一般资料,记录身高、体重等。结果:糖尿病合并PVD组血清Cys C水平明显高于无PVD、NC组,差异有统计学意义(P<0.05),且糖尿病无PVD组与NC组相比,糖尿病无PVD组血清Cys C水平也高于NC组,差异也有统计学意义(P<0.05)。2型糖尿病有PVD与Cys C、糖尿病病程(Course)、血糖(FBG)、年龄(Age)相关(P<0.01)。多元Logistic回归分析显示胱抑素C、病程、年龄是PVD的危险因素。结论:2型糖尿病并PVD的发生与发展除了与病程、年龄有关外,还可能与胱抑素C有关。 Objective:To investigate the relationship between serum cystatin C and peripheral vascular disease(PVD) in type 2 diabetes.Methods:We selected 100 inpatients with diabetes(50 None PVD,50 PVD) and 40 healthy people as normal control(NC).We determined all of the subjects’ fasting blood glucose,blood fat,Cys C and the general clinical data,body height,weight,etc.Results:The serum Cys C of diabetes with PVD group was obviously higher than that of NPVD group and NC group,with significant difference(P〈0.05).The Cys C of NPVD group was higher than that of NC group,with significant difference(P〈0.05).The analysis showed that PVD was positively correlated with FBG,age,course,Cys C(P〈0.01).Multinomial logistic regression showed that age,course,Cys C were risk factors of PVD.Conclusions:These finds suggested that the cause and development of PVD is associated with course,age,and also associated with Cys C.
出处 《现代生物医学进展》 CAS 2010年第22期4326-4328,4348,共4页 Progress in Modern Biomedicine
关键词 2型糖尿病 下肢血管病变 胱抑素C Type 2 Diabetes peripheral vascular disease cystatin C
  • 相关文献

参考文献12

二级参考文献87

  • 1冯建芳,汪淑荣,李平,赵一鸣,孙诠,师树古,陈明哲.急性心肌梗塞病人血清巯基蛋白酶抑制肽C的变化[J].基础医学与临床,1995,15(4):45-47. 被引量:20
  • 2吴光哲,张必利,郑兴,秦永文.慢性肾脏病与冠心病相关性的临床研究[J].心血管康复医学杂志,2006,15(5):447-450. 被引量:17
  • 3David J neuman. Cystatin C[J]. Ann Clin bioehem, 2002,39: 89.
  • 4Tenstad O,Roald AB ,Grubb A,et al. Renal handing of rediolabelled human, cystatin C in the rat[J].Stand J Clin Lab Invest ,1996,56:409.
  • 5Brahamson M,Olafsson I ,Palsdottir A,et al. Structure and expression of the human cystatin C gene[J].Biochem J, 1990,268: 287.
  • 6Fanos V,Mussap M,Plebani M,et al. Cystatin C in pediatric: Presnt situation and propect[J].Minerva Pediatr, 1999,5 1(5): 167.
  • 7Newman DJ,Thakkar H,Edwards RG,et al. Serum eystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum ereatinine[J].Kidney Int, 1995,47: 312.
  • 8Chimeman N, Brguljan PM,Krasovec M,et al.Twenty-four variation of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subject[J]. Clin Chem Acta,2000,291:89.
  • 9Lindhoh JS,Erlandsen EJ, Henneberg EW.Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms[J]. Br J Surg,2001,88 : 1472.
  • 10Zore I, Krasovec M, Cimemlan N,et al. Cathepsin B/eystatin C complex levels in sera from patients with lung and colorectal cancer[J]. Biol Chem,2001,382(5):805.

共引文献134

同被引文献15

  • 1杜桂芹,程欣弘,常曼丽,王秀云.下肢静脉曲张患者的血流变及血脂分析[J].中国血液流变学杂志,2004,14(2):263-264. 被引量:5
  • 2姜镇,栗印军.胱抑素C与冠状动脉粥样硬化类疾病的相关性研究进展[J].中国医师进修杂志,2014,37增刊1:177-179.
  • 3丁健,傅颖.血清胱抑素C的临床应用[C]//中华医学会检验分会.中华医学会第七次全国中青年检验医学学术会议论文汇编.北京:中华医学会,2012.
  • 4Page MK,Btikki J, Luppa P, et al. Clinical value of cysta- tin C determination[J]. Clin Chim Acta, 2000,297 (1/2) : 67-72.
  • 5Wang B, Sun J, Kitamoto S, et al. Cathepsin S controls an- giogenesis and tumor growth via matrix-derived angiogen- ic factors[J]. J Biol Chem, 2006,281 (9) : 6020-6029.
  • 6Filler G, B6kenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR-history, indications, and future research [J]. Clin Biochem,2005,38(1) : 1-8.
  • 7Sukhova GK,Wang B, Libby P, et al. Cystatin C deficien- cy increases elastic lamina degradation and aortic dilata- tion in apolipoprotein E-null mice[J]. Circ Res, 2005,96 (3) :368-375.
  • 8Grados F, Depriester C, Cayrolle G, et al. Long-term ob- servations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty[J]. Rheumatology(Oxford), 2000,39(12) :1410-1414.
  • 9Dubniks M, Persson J, Gr/inde PO. Plasma volume expan- sion of 5% albumin, 4% gelatin, 6% HES 130/0.4, and normal saline under increased microvascular permeability in the rat[J]. Intensive Care Med,2007,33(2) :293-299.
  • 10陆新虹.胱抑素C在糖尿病中的应用研究进展[J].医学综述,2009,15(19):2997-2999. 被引量:5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部